垂体腺瘤内镜经鼻手术中低剂量阿司匹林短期停药患者的管理与术后出血风险
单中心回顾性分析2008年12月至2022年6月共304例接受内镜经鼻蝶手术的垂体腺瘤患者,其中45例(14.8%)术前服用低剂量阿司匹林并短期停药。短期停药患者术后出血率未增加,术后需手术的出血仅见于1例未服药患者(0.3%),停药组与未服药组的鼻出血率分别为0.3%与2.3%。
要点
- 45例(14.8%)术前服阿司匹林患者短期停药,术后出血率未增加。
- 36例(80%)停药<2天,6例(13.3%)>2且<4天,3例(6.7%)>4且<7天。
- 服药组年龄更大(68.3±8.6岁 vs 57.9±14.1岁,p<0.01),激素活跃肿瘤比例更低(11.1% vs 25.1%,p<0.05)。
核心结论
- 短期停用低剂量阿司匹林与内镜经鼻蝶手术治疗垂体腺瘤患者术后出血率增加无关。
研究设计与样本
- 单中心回顾性分析,连续纳入2008年12月至2022年6月接受内镜经鼻蝶手术的垂体腺瘤患者304例,其中45例(14.8%)术前服用阿司匹林并短期停药。
主要发现
- 45例(14.8%)术前服阿司匹林患者中,36例(80%)停药<2天,6例(13.3%)停药>2且<4天,3例(6.7%)停药>4且<7天。
- 术后需手术的出血:未服阿司匹林组1例(0.3%),停药组0例;术后鼻出血:停药组1例(0.3%) vs 未服药组7例(2.3%)。
- 服药组较未服药组年龄更大(68.3±8.6岁 vs 57.9±14.1岁,p<0.01),激素活跃肿瘤比例更低(11.1% vs 25.1%,p<0.05)。
- 两组肿瘤特征(肿瘤延伸、肿瘤体积、最大直径)无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To analyze the risk of postoperative bleeding following endoscopic endonasal transsphenoidal surgery (EETS) for treatment of pituitary adenomas (PA) in patients with short-term discontinuation of low-dose aspirin, if required for prevention of artherothrombotic disease (ATD). METHODS: Patients with preoperative aspirin medication were identified in this single-center retrospective analysis of consecutive patients with PA, who underwent EETS between December 2008 and June 2022. Aspirin was discontinued perioperatively less than 2 days, > 2 and < 4 days, and > 4 and < 7 days according to the assumed risk of perioperative ATD. For those patients, the rate of postoperative bleeding, which required surgery, was compared to patients without aspirin. RESULTS: Forty-five (14.8%) out of 304 patients underwent EETS with short-term perioperative aspirin discontinuation. Thirty-six (80%) patients discontinued aspirin < 2 days, 6 (13.3%) patients > 2 and < 4 days, and 3 patients (6.7%) > 4 but < 7 days. Postoperative bleeding rate was not increased in patients with short-term perioperative aspirin discontinuation. One patient (0.3%) without perioperative aspirin medication underwent revision surgery for treatment of postoperative hemorrhage with suprasellar extension. Eight patients (2.6%) had postoperative epistaxis (1 patient (0.3%) with short-term discontinuation and 7 patients (2.3%) without aspirin). Patients with perioperative aspirin were significantly older (68.3 ± 8.6 vs. 57.9 ± 14.1; p < 0.01) and had a significantly lower rate of hormonally active tumors (11.1% vs. 25.1%; p < 0.05) compared to patients without aspirin. No differences were found for tumor characteristics (tumor extension, tumor volume, largest diameter) between both groups. CONCLUSION: Short-term discontinuation of low-dose aspirin was not associated with increased rate of postoperative bleeding in patients, who underwent EETS for treatment of PA.
引用
- Enciu A, Loeschner D, Alhallak M, et al. Management and risk of postoperative bleeding in patients with low-dose antiplatelet aspirin medication during endoscopic endonasal surgery for pituitary adenomas. Acta Neurochir (Wien). 2023. PMID: 37668789. doi:10.1007/s00701-023-05766-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。